The drug resistance-related protein LRP is the human major vault protein.Scheffer G.L., Wijngaard P.L.J., Flens M.J., Izquierdo M.A., Slovak M.L., Pinedo H.M., Meijer C.J.L.M., Clevers H.C., Scheper R.J.Nat. Med. 1:578-582(1995)
Scheffer G.L.
Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter.Lange C., Walther W., Schwabe H., Stein U.Biochem. Biophys. Res. Commun. 278:125-133(2000)
A small upstream open reading frame causes inhibition of human major vault protein expression from a ubiquitous mRNA splice variant.Holzmann K., Ambrosch I., Elbling L., Micksche M., Berger W.FEBS Lett. 494:99-104(2001)
Quadroni M., Potts A., Barblan J., Bienvenut W.V.Submitted (JAN-2005)
to UniProtKB
Vaults and telomerase share a common subunit, TEP1.Kickhoefer V.A., Stephen A.G., Harrington L., Robinson M.O., Rome L.H.J. Biol. Chem. 274:32712-32717(1999)
PTEN associates with the vault particles in HeLa cells.Yu Z., Fotouhi-Ardakani N., Wu L., Maoui M., Wang S., Banville D., Shen S.-H.J. Biol. Chem. 277:40247-40252(2002)
The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling.Kolli S., Zito C.I., Mossink M.H., Wiemer E.A.C., Bennett A.M.J. Biol. Chem. 279:29374-29385(2004)
A novel human zinc finger protein ZNF540 interacts with MVP and inhibits transcriptional activities of the ERK signal pathway.Xiang Z., Yuan W., Luo N., Wang Y., Tan K., Deng Y., Zhou X., Zhu C., Li Y., Liu M., Wu X., Li Y.Biochem. Biophys. Res. Commun. 347:288-296(2006)
Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling.Kim E., Lee S., Mian M.F., Yun S.U., Song M., Yi K.-S., Ryu S.H., Suh P.-G.FEBS J. 273:793-804(2006)
The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals.Steiner E., Holzmann K., Pirker C., Elbling L., Micksche M., Sutterluety H., Berger W.J. Cell Sci. 119:459-469(2006)
Regulatory role of human AP-endonuclease (APE1/Ref-1)
in YB-1-mediated activation of the multidrug resistance gene MDR1.Chattopadhyay R., Das S., Maiti A.K., Boldogh I., Xie J., Hazra T.K., Kohno K., Mitra S., Bhakat K.K.Mol. Cell. Biol. 28:7066-7080(2008)
A quantitative atlas of mitotic phosphorylation.Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008)
Initial characterization of the human central proteome.Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.BMC Syst. Biol. 5:17-17(2011)
Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T., Giglione C.Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012)
N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012)
An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., Ye M., Zou H.J. Proteomics 96:253-262(2014)
Solution structure of a two-repeat fragment of major vault protein.Kozlov G., Vavelyuk O., Minailiuc O., Banville D., Gehring K., Ekiel I.J. Mol. Biol. 356:444-452(2006)